keyword
https://read.qxmd.com/read/38690558/repeated-occurrence-of-severe-hypotension-associated-with-azithromycin-infusion-in-a-patient-with-fulminant-myocarditis-a-case-report
#1
Max Lenz, Konstantin A Krychtiuk, Robert Zilberszac, Walter S Speidl, Gottfried Heinz
BACKGROUND: Intravenous administration of azithromycin has been linked to severe hypotension in some case reports in the past. We report a further case of profound shock requiring excessive use of vasopressors and extracorporeal membrane oxygenation (ECMO). CASE SUMMARY: An 18-year-old Caucasian male was admitted due to fulminant myocarditis and signs of cardiogenic shock. He had to be put on venoarterial ECMO only hours after admission. Due to the occurrence of disseminated intravascular coagulation and heparin-induced thrombocytopenia, haemodynamic support was discontinued on Day 8...
April 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38689858/a-case-report-of-mycoplasma-pneumoniae-induced-fulminant-myocarditis-in-a-15-year-old-male-leading-to-cardiogenic-shock-and-electrical-storm
#2
Chengrui Zhu, Bo Hu, Xiaotong Li, Weiying Han, Yingjian Liang, Xiaochun Ma
Mycoplasma pneumoniae (M. pneumoniae) is a well-recognized pathogen primarily associated with respiratory tract infections. However, in rare instances, it can lead to extrapulmonary manifestations, including myocarditis. We present a case of a 15-year-old male who developed fulminant myocarditis, cardiogenic shock, and cardiac electrical storm attributed to M. pneumoniae infection. He underwent a combination of intra-aortic balloon pump (IABP) and veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for cardiac support, ultimately surviving despite the intracardiac thrombus formation and embolic stroke...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38681343/clinical-presentation-diagnosis-treatment-and-outcomes-of-myocarditis-in-children-a-tertiary-care-hospital-experience
#3
JOURNAL ARTICLE
Khadim Khan, Ijaz Hussain, Saadia Ilyas, Zaland A Yousafzai, Rida Khan, Farman Ali
Background Clinical presentation, diagnosis, and treatment of myocarditis in children can be highly challenging, and results can vary greatly. Research on the precise processes of myocardial injury, including the effects of viral infections and newly identified variables like COVID-19, is still underway. Though treatment approaches, such as immunosuppressive therapy, are still debatable, diagnostic methods such as cardiac MRI and biomarkers show promise in improving diagnostic accuracy. The purpose of this study is to describe the spectrum of pediatric acute myocarditis, assess existing therapy approaches, and develop regional guidelines based on the experience of a tertiary care institution...
March 2024: Curēus
https://read.qxmd.com/read/38672187/storytelling-of-myocarditis
#4
REVIEW
Gaetano Thiene
In 1900, Fiedler first reported autopsy cases with peculiar inflammation of the myocardium, which he named interstitial myocarditis. He postulated an isolated cardiac inflammation of the myocardium in the absence of multiorgan involvement and with a poor prognosis due to invisible microorganisms, which years later would have been identified as viruses. The revision of original histologic sections by Schmorl showed cases with lymphocytes and others with giant-cell inflammatory histotypes. The in vivo diagnosis of myocarditis became possible thanks to right cardiac catheterization with endomyocardial biopsy (EMB)...
April 9, 2024: Biomedicines
https://read.qxmd.com/read/38658337/fatal-systemic-capillary-leak-syndrome-in-a-patient-with-a-covid-19-infection
#5
JOURNAL ARTICLE
Hiroaki Kawano, Masataka Umeda, Tomohiro Honda, Ryosuke Iwasaki, Shinji Okano, Ryohei Akashi, Tomohiro Koga, Koichi Izumikawa, Atsushi Kawakami, Koji Maemura
A 29-year-old Japanese woman was admitted to our hospital with a fever, cardiogenic shock, and cardiac arrest. Laboratory data indicated multiple organ failure in addition to hemoconcentration, hypoalbuminemia, and myocardial damage. The coronary angiography findings were normal, and fulminant myocarditis was suspected. Venoarterial peripheral extracorporeal membrane oxygenation and an Impella CP left ventricular assist device were initiated, along with the administration of positive inotropic agents. However, hypovolemic shock and hypoalbuminemia progressed along with severe anemia, and the patient died 18 hours after admission...
April 23, 2024: Internal Medicine
https://read.qxmd.com/read/38654456/covid-19-vaccination-related-myocarditis-what-we-learned-from-our-experience-and-what-we-need-to-do-in-the-future
#6
REVIEW
Jae-Hyeong Park, Kye Hun Kim
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has led to a global health crisis with substantial mortality and morbidity. To combat the COVID-19 pandemic, various vaccines have been developed, but unexpected serious adverse events including vaccine-induced thrombotic thrombocytopenia, carditis, and thromboembolic events have been reported and became a huddle for COVID-19 vaccination. Vaccine-related myocarditis (VRM) is a rare but significant adverse event associated primarily with mRNA vaccines...
April 1, 2024: Korean Circulation Journal
https://read.qxmd.com/read/38651079/lethal-immune-myocarditis-and-myasthenia-gravis-due-to-anti-pd-1-treatment-for-a-bladder-cancer-patient-a-case-report-and-possible-treatment-inspiration
#7
Pan Gao, Xinyu Li, Ziqiu He, Hongbo Zhang, Zhi Zhang, Zonglai Liu
Immune checkpoint inhibitors (ICI) have become a new hope for many patients with advanced cancer by blocking tumor immune escape. Bladder cancer is a common malignant tumor of the urinary tract epithelium that often relapses and metastasizes after surgery, chemotherapy, and radiotherapy. Immunotherapy has dramatically improved patient survival rates and clinical benefits as a new, potentially effective therapy. However, avoidance of various immune-related adverse events (irAEs) remains an implausible idea. ICI-induced myocarditis is different from viral myocarditis, and mortality is still high with the current treatment...
2024: International Medical Case Reports Journal
https://read.qxmd.com/read/38650811/eosinophilic-myocarditis-resulting-in-ventricular-tachycardia-storm
#8
Dylan Hengst, Daniel Kandah, Ravinder Dervesh, Michael Ellerman, Justin Ugwu, Jennifer Goerbig-Campbell, Dwayne Campbell
Eosinophilic myocarditis (EM) is a rare but potentially fatal complication of sustained eosinophilia that is characterized by eosinophilic infiltration into myocardial tissue. There are various etiologies of EM that can be classified into general categories: reactive, clonal, and idiopathic. We present a case of EM caused by chronic eosinophilic leukemia, a rare myeloproliferative neoplasm that frequently presents with sustained peripheral eosinophilia. This case displays several serious complications of EM, including recurrent ventricular tachycardia storm, cardiogenic shock, and mural thrombus formation despite anticoagulation...
March 2024: Curēus
https://read.qxmd.com/read/38638286/use-of-endoscopic-hand-suturing-to-treat-refractory-bleeding-from-a-gastric-ulcer-in-a-patient-with-a-left-ventricular-assist-device
#9
Masahiro Kondo, Tomohiro Nagasue, Takehiro Torisu, Satoshi Miyazono, Yuichi Matsuno, Takahisa Nagahata, Toru Hashimoto, Takeo Fujino, Akira Shiose, Takanari Kitazono
We herein describe a 49-year-old man with severe heart failure due to fulminant myocarditis who underwent left ventricular assist device implantation and received clopidogrel and warfarin as antithrombotic agents. The patient developed anemia secondary to chronic bleeding gastric hyperplastic polyps, necessitating endoscopic mucosal resection. Despite attempts to manage post-endoscopic mucosal resection bleeding from a gastric ulcer by endoscopic hemostasis using hemostatic forceps, local hemostatic agents, and polyglycolic acid sheets, the bleeding persisted...
April 2024: DEN Open
https://read.qxmd.com/read/38638282/tricuspid-transcatheter-edge-to-edge-repair-in-a-72-year-old-patient-with-a-left-ventricular-assist-device-and-prior-mitral-edge-to-edge-repair-a-case-report
#10
Stephan Staubach, Michael Sailer, Johannes Koch, Anatol Maier, Andreas Jeron
BACKGROUND: We report a case of a 72-year-old patient developing a significant tricuspid regurgitation (TR) 6 years after a left ventricular assist device (LVAD) implantation. The aim of this case is to demonstrate the feasibility of transcatheter edge-to-edge repair (TEER) of the tricuspid valve and the excellent clinical benefit in long-term follow-up in an LVAD patient. CASE SUMMARY: Our patient presented with recurrent acute heart failure syndrome. After a fulminant myocarditis in 2005, his previous treatment consisted of cardiac resynchronization therapy, TEER of the mitral valve, and LVAD (HeartMate III) implantation...
March 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38601042/a-case-report-on-pheochromocytoma-mimicking-as-fulminant-myocarditis-a-diagnostic-challenge
#11
Yanwei Cheng, Ning Ding, Longan Wang, Lijie Qin
We present an exceptional case of a 53-year-old female, initially misdiagnosed with fulminant myocarditis, but later correctly diagnosed with pheochromocytoma. The presentation of the patient included a spectrum of symptoms such as headache, chest discomfort, palpitations, and dyspnea, following the intake of Domperidone. Two weeks prior to admission, the patient had experienced episodes of diarrhea and a low-grade fever. Unresolved symptoms and an unmanageable surge in blood pressure despite comprehensive fulminant myocarditis treatment prompted further investigation...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38597982/anterolateral-papillary-muscle-suction-causing-low-flow-in-a-covid-19-patient-without-medical-history-a-case-report-of-central-extracorporeal-life-support-with-left-ventricular-apex-decompression
#12
JOURNAL ARTICLE
Tomoaki Miyake, Kimito Minami, Masahiro Kazawa, Naoki Tadokoro, Kohei Tonai, Satsuki Fukushima
BACKGROUND: Left ventricular (LV) decompression is an essential strategy for improving early survival in patients with refractory cardiogenic shock. Low pump flow in patients on extracorporeal life support (ECLS) with LV apex decompression is a life-threatening issue. However, identifying the underlying causes of low flow can be challenging. CASE PRESENTATION: A 38-year-old woman with COVID-19-related fulminant myocarditis was treated with central ECLS with LV apex decompression...
April 10, 2024: JA Clinical Reports
https://read.qxmd.com/read/38592041/mechanical-circulatory-support-systems-in-fulminant-myocarditis-recent-advances-and-outlook
#13
REVIEW
Max Lenz, Konstantin A Krychtiuk, Robert Zilberszac, Gottfried Heinz, Julia Riebandt, Walter S Speidl
Background: Fulminant myocarditis (FM) constitutes a severe and life-threatening form of acute cardiac injury associated with cardiogenic shock. The condition is characterised by rapidly progressing myocardial inflammation, leading to significant impairment of cardiac function. Due to the acute and severe nature of the disease, affected patients require urgent medical attention to mitigate adverse outcomes. Besides symptom-oriented treatment in specialised intensive care units (ICUs), the necessity for temporary mechanical cardiac support (MCS) may arise...
February 20, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38572641/changes-in-cardiac-function-following-fulminant-myocarditis
#14
JOURNAL ARTICLE
Koshiro Kanaoka, Kenji Onoue, Satoshi Terasaki, Michikazu Nakai, Yoshitaka Iwanaga, Yoshihiro Miyamoto, Yoshihiko Saito
BACKGROUND: The natural history of myocardial dysfunction in patients with fulminant myocarditis is poorly understood. This study aims to evaluate changes in cardiac function in patients with fulminant myocarditis using a nationwide registry in Japan. METHODS: This retrospective cohort study included patients with biopsy-proven fulminant myocarditis and available for left ventricular ejection fraction (LVEF). We described the LVEF on admission, at discharge, and 1 year after discharge...
April 4, 2024: Circulation. Heart Failure
https://read.qxmd.com/read/38567279/two-case-reports-of-fulminant-giant-cell-myocarditis-treated-with-rabbit-anti-thymocyte-globulin
#15
Colin Bartz-Overman, Sarah Li, Balaram Puligandla, Nalini Colaco, Johannes Steiner, Luke Masha
BACKGROUND: Giant cell myocarditis (GCM) is an inflammatory form of acute heart failure with high rates of cardiac transplantation or death. Standard acute treatment includes multi-drug immunosuppressive regimens. There is a small but growing number of case reports utilizing rabbit anti-thymocyte globulin in severe cases. CASE SUMMARY: Two cases are presented with similar presentations and clinical courses. Both are middle-aged patients with no significant past medical history, who presented with new acute decompensated heart failure that quickly progressed to cardiogenic shock requiring inotropic and mechanical circulatory support...
April 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38556333/clinical-value-of-troponin-levels-to-cardiac-function-and-prognosis-in-patients-with-fulminant-myocarditis
#16
JOURNAL ARTICLE
Naoki Shibata, Toru Kondo, Takahiro Okumura, Takahiro Imaizumi, Kaoru Dohi, Hideo Izawa, Nobuyuki Ohte, Tetsuya Amano, Toyoaki Murohara
Troponin (Tn) is a biomarker related to myocardial necrosis and is elevated in patients with myocarditis. This study aimed to investigate the association between cardiac Tn levels and the course of cardiac function, and prognosis in patients with fulminant myocarditis (FM) receiving percutaneous mechanical circulatory support (MCS).We used data from a multicenter retrospective registry, CHANGE PUMP 2, which included 216 patients with FM who required MCS. Among them, 141 patients whose Tn levels were available were analyzed...
2024: International Heart Journal
https://read.qxmd.com/read/38555967/nursing-care-of-a-child-with-delirium-receiving-venoarterial-extracorporeal-membrane-oxygenation-a-case-report
#17
JOURNAL ARTICLE
Cong-Hui Fu, Yan Li, Yu-Cai Zhang, Xiao-Ya Yang, Ji Liu, Min-Jie Ju, Ting-Ting Xu
INTRODUCTION: Children receiving extracorporeal membrane oxygenation are prone to delirium. This case report describes the nursing care of a child with delirium who received venoarterial extracorporeal membrane oxygenation. Relevant interventions and precautions are also discussed. CLINICAL FINDINGS: A 6-year-old girl was admitted to the pediatric intensive care unit with a 2-day history of vomiting and fever. The child underwent cannulation for venoarterial extracorporeal membrane oxygenation...
April 1, 2024: Critical Care Nurse
https://read.qxmd.com/read/38545023/complete-recovery-after-fulminant-myocarditis-in-a-patient-with-covid-19
#18
Vasiliki Kitsou, Torbjørn Lunde, Atle Solholm, Bjørn Blomberg, Sahrai Saeed
The clinical spectrum of Coronavirus disease 2019 (COVID-19) varies from asymptomatic infection to severe disease with multiorgan dysfunction. Cardiovascular involvement is common and in rare cases can lead to serious complications, such as fulminant myocarditis. The clinical course of COVID-19 myocarditis varies from complete recovery to death in rare cases. The pathophysiology of COVID-19-related myocarditis is still unclear but is believed to involve direct viral injury and cardiac damage due to the host's immune response...
2024: Pakistan Journal of Medical Sciences Quarterly
https://read.qxmd.com/read/38536007/acute-myocarditis-an-overview-of-pathogenesis-diagnosis-and-management
#19
JOURNAL ARTICLE
Marina Zafeiri, Kristopher Knott, Temi Lampejo
Acute myocarditis encompasses a diverse presentation of inflammatory cardiomyopathies with infectious and non-infectious triggers. The clinical presentation is heterogeneous, from subtle symptoms like mild chest pain to life-threatening fulminant heart failure requiring urgent advanced hemodynamic support. This review provides a comprehensive overview of the current state of knowledge regarding the pathogenesis, diagnostic approach, management strategies, and directions for future research in acute myocarditis...
March 27, 2024: Panminerva Medica
https://read.qxmd.com/read/38524063/fulminant-myocarditis-and-venoarterial-extracorporeal-membrane-oxygenation-a-systematic-review
#20
REVIEW
Spencer E Briglio, Viraj Khanduja, Justin D Lothan, Vasavi Rakesh Gorantla
This systematic review aimed to look at the effectiveness of venoarterial extracorporeal membrane oxygenation (VA-ECMO) therapy in treating fulminant myocarditis and evaluating the optimal length of time a patient should be placed on VA-ECMO. Fulminant myocarditis is a potentially life-threatening medical condition most commonly brought on by cardiogenic shock, which often progresses to severe circulatory compromise, requiring the patient to be placed on some form of mechanical circulatory assistance to maintain adequate tissue perfusion...
February 2024: Curēus
keyword
keyword
59963
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.